This is also supported by the fact that IL-1β silencing reduces OSCC tumor size in vivo [77] and that elevated IL-1β expression has been related with lymph node metastasis in OSCC [82]. Here, IL1B is linked to metastatic malignant neoplasm in the lymph nodes.